Source:http://linkedlifedata.com/resource/pubmed/id/10529286
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1999-12-6
|
pubmed:abstractText |
Synthetically produced meiosis-activating sterol, a sterol originally derived from follicular fluid (FF-MAS), induces meiotic maturation of mouse oocytes in vitro. We therefore compared FF-MAS-induced maturation of naked mouse oocytes arrested in prophase I by either hypoxanthine (Hx) or forskolin (Fo) with spontaneous maturation of naked oocytes. FF-MAS-treated oocytes overcame the meiotic block by Hx or Fo, although germinal vesicle breakdown was delayed by 11 h and 7 h, respectively. We also investigated the influence of FF-MAS on chromosome, microtubule, and ultrastructural dynamics in Hx-cultured oocytes by immunocytochemistry and electron microscopy. Similarly to spontaneously matured oocytes, chromosomes became aligned, a barrel-shaped spindle formed, and overall organelle distribution was normal in FF-MAS-matured oocytes. The number of small cytoplasmic asters was elevated in FF-MAS-treated oocytes. Although the number of cortical granules (CGs) was similar to that in spontaneously matured oocytes, the overall distance between CGs and oolemma was increased in the FF-MAS group. These observations suggest that the initiation of meiotic maturation in FF-MAS-treated oocytes in the presence of high cAMP levels leads to a delayed but otherwise normal nuclear maturation. FF-MAS appears to improve oocyte quality by supporting microtubule assembly and by delaying CG release, which is known to contribute to reduced fertilization.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/4,4-dimethyl-5alpha-cholest-8,14,24-...,
http://linkedlifedata.com/resource/pubmed/chemical/Cholestadienols,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Forskolin,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoxanthine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0006-3363
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1362-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10529286-Animals,
pubmed-meshheading:10529286-Cell Nucleus,
pubmed-meshheading:10529286-Cholestadienols,
pubmed-meshheading:10529286-Chromosomes,
pubmed-meshheading:10529286-Cyclic AMP,
pubmed-meshheading:10529286-Cytoplasm,
pubmed-meshheading:10529286-Cytoskeleton,
pubmed-meshheading:10529286-Female,
pubmed-meshheading:10529286-Forskolin,
pubmed-meshheading:10529286-Hypoxanthine,
pubmed-meshheading:10529286-Meiosis,
pubmed-meshheading:10529286-Mice,
pubmed-meshheading:10529286-Mice, Inbred C57BL,
pubmed-meshheading:10529286-Mice, Inbred DBA,
pubmed-meshheading:10529286-Microscopy, Electron,
pubmed-meshheading:10529286-Microscopy, Fluorescence,
pubmed-meshheading:10529286-Microtubules,
pubmed-meshheading:10529286-Oocytes
|
pubmed:year |
1999
|
pubmed:articleTitle |
Nuclear and cytoplasmic maturation of mouse oocytes after treatment with synthetic meiosis-activating sterol in vitro.
|
pubmed:affiliation |
Research Laboratories of Schering AG, Berlin, Germany. christa.hegelehartung@schering.de
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|